Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26F21ES
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,280.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,280 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kisqali 600 mg daily dose (63 tablets) on January 23, 2026, with an ultimate completion date of February 13, 2026. This non-set-aside competitive award was performed at the contractor's Conshohocken, Pennsylvania location. Kisqali (ribociclin) is a prescription medication used in oncology treatment, reflecting the pharmaceutical distributor's role in supplying specialized medical commodities to federal healthcare systems. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), operates as a major pharmaceutical distributor providing critical medical products to military and veteran healthcare programs.
This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. The parent company, Cencora, Inc., holds the primary IDC vehicle (valued at up to $999,999,999 through December 2031) that enables comprehensive pharmaceutical support to Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities globally. The contract structure demonstrates the company's established capability to efficiently fulfill government requirements for specialized medications and medical supplies across multiple therapeutic domains supporting military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F21ES?
SPE2DR26F21ES was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F21ES worth?
The government has obligated $12,280 on SPE2DR26F21ES.
Is contract SPE2DR26F21ES an order under another contract?
Yes. SPE2DR26F21ES is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21ES competed?
The extent of competition for SPE2DR26F21ES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award